Search results
A single infusion of a gene-editing medicine may control inherited high LDL cholesterol
NewMediaWire via Yahoo Finance· 7 months agoResearch Highlights: In an interim report from the first study in people, a single infusion of a...
Regeneron (REGN) Gets Label Extension for Cholesterol Drug
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN announced that the FDA has approved a label extension for the...
Verve's Stock Price Could Continue To Rise Through Clinical Progress - Despite Worries About...
Benzinga via Yahoo Finance· 2 years agoCredit Suisse has initiated coverage on Verve Therapeutics Inc (NASDAQ: VERV) with a Neutral rating...
Gene Editing Experiment Halted as Patient Gets Weird Side Effects
Futurism via Yahoo News· 3 months agoThe experimental biotech startup Verve Therapeutics has paused the first phase of a buzzy human...
Regeneron (REGN) Gets FDA Nod for Praluent Label Extension
Zacks via Yahoo Finance· 3 months agoRegeneron (REGN) obtains FDA approval for Praluent as an adjunct to diet and other LDL-C, lowering...
If You Invested $1000 in Regeneron 10 Years Ago, This Is How Much You'd Have Now
Zacks via Yahoo Finance· 2 years agoFor most investors, how much a stock's price changes over time is important. This factor can impact...
Praluent vs. Repatha: Similaries and Differences
Verywell Health via Yahoo News· 4 months agoPraluent and Repatha are PCSK9 inhibitors that can lower low-density lipoprotein (LDL, or "bad") cholesterol levels in certain people. Though similar,...
Verve Loses A Third Of Its Value As Safety Concerns Plague Its Gene-Editing Drug
Investor's Business Daily· 7 months agoVerve Therapeutics stock crashed Monday as safety concerns plagued its gene-editing approach to...
Verve (VERV) Pauses Enrollment in Cholesterol Study, Stock Falls
Zacks via Yahoo Finance· 3 months agoVerve (VERV) stops enrollment in the phase Ib study of gene therapy candidate VERVE-10 to reduce...
Could The Next CRISPR From Verve, Beam Signal The End To High Cholesterol?
Investor's Business Daily· 2 years agoVerve Therapeutics said Tuesday it used a next-generation form of CRISPR to edit the genes of...